Corvus Pharma reports encouraging data for its eczema drug soquelitinib, showing strong skin improvement and no serious ...

Biotech stock Corvus Pharmaceuticals catapulted to a nine-year high Tuesday on promising results in eczema treatment.

The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate to severe atopic dermatitis (AD) in children 12-17 years old, ...

Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children and adults. It often causes itching, redness, dryness, flaking, and sometimes ...

ORLANDO (Nov. 6, 2025) – New research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that the timing of when eczema begins, as well as ...

Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of eczema, known as atopic dermatitis, is characterized by persistent itching ...

Winters are known to worsen symptoms of eczema due to dropping temperatures.It is believed that around 8 million people in ...

Kim H. from Nevada writes: “I read an article you wrote about how gut health affects the brain and other parts of the body. Our 19-year-old son has severe eczema and is living in Hong Kong. We thought ...

Rising misuse of unregulated creams and delays in treatment are driving more severe eczema cases in Malaysia, specialists ...